Christopher G. Hayes - Oct 9, 2024 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
VRCA
Transactions as of
Oct 9, 2024
Transactions value $
$0
Form type
4
Date filed
10/11/2024, 04:15 PM
Previous filing
Aug 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRCA Employee Stock Option (right to buy) Award $0 +50K $0.00 50K Oct 9, 2024 Common Stock 50K $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the total shares subject to the option shall vest on each of April 9, 2025 and October 9, 2025, subject to the Reporting Person's continuous service through such vesting date.